November 26, 2018 Dr. Christopher Stevens Retention Bonus Agreement Dear Chris,Retention Bonus Agreement • November 27th, 2018 • Arsanis, Inc. • Biological products, (no disgnostic substances) • Massachusetts
On behalf of Arsanis, Inc. (the “Company”), I would like to thank you for your continued service to the Company and emphasize your importance to our organization and its success. I am pleased to inform you that, as an incentive for your continued service to the Company, the Company is making you eligible for a special retention bonus, subject to the satisfaction of the terms and conditions described in this letter agreement.
ARSANIS, INC. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • November 27th, 2018 • Arsanis, Inc. • Biological products, (no disgnostic substances) • Delaware
Arsanis, Inc. (the “Company”) has selected you to receive the following restricted stock award pursuant to its 2017 Equity Incentive Plan. The terms and conditions attached hereto are also a part hereof.
FORM OF SUPPORT AGREEMENTForm of Support Agreement • November 27th, 2018 • Arsanis, Inc. • Biological products, (no disgnostic substances) • Delaware
This Support Agreement (this “Agreement”) is made and entered into as of November [_], 2018, by and among X4 Pharmaceuticals, Inc., a Delaware corporation (“Merger Partner”), Arsanis, Inc., a Delaware corporation (“Public Company”), and the undersigned stockholder (the “Stockholder”) of Public Company.
